Brokerages predict that Iqvia Holdings Inc (NYSE:IQV) will post earnings of $1.34 per share for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have issued estimates for Iqvia’s earnings. The lowest EPS estimate is $1.31 and the highest is $1.38. Iqvia posted earnings of $1.09 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 22.9%. The business is expected to issue its next quarterly earnings report before the market opens on Wednesday, February 14th.
According to Zacks, analysts expect that Iqvia will report full-year earnings of $4.62 per share for the current year, with EPS estimates ranging from $4.59 to $4.66. For the next fiscal year, analysts anticipate that the company will post earnings of $5.35 per share, with EPS estimates ranging from $5.15 to $5.53. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for Iqvia.
Several analysts have weighed in on the company. Mizuho set a $97.00 price objective on Iqvia and gave the company a “hold” rating in a research report on Wednesday, January 24th. SunTrust Banks reiterated a “hold” rating and issued a $110.00 price objective on shares of Iqvia in a research report on Monday, January 22nd. Zacks Investment Research downgraded Iqvia from a “buy” rating to a “hold” rating in a research report on Friday, January 19th. Evercore ISI assumed coverage on Iqvia in a research report on Thursday, January 18th. They issued an “outperform” rating and a $112.00 price objective for the company. Finally, Mitsubishi UFJ Financial Group assumed coverage on Iqvia in a research report on Friday, December 15th. They issued a “neutral” rating and a $112.00 price objective for the company. Seven investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Iqvia presently has a consensus rating of “Buy” and a consensus target price of $109.71.
In other news, Director John Connaughton sold 1,163,191 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $102.00, for a total transaction of $118,645,482.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Ari Bousbib sold 46,080 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $101.79, for a total value of $4,690,483.20. The disclosure for this sale can be found here. Insiders have sold 8,727,078 shares of company stock worth $890,124,079 over the last three months. Insiders own 6.40% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Winslow Evans & Crocker Inc. purchased a new stake in Iqvia in the fourth quarter worth $123,000. IFP Advisors Inc purchased a new stake in Iqvia in the fourth quarter worth $200,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Iqvia in the fourth quarter worth $209,000. Atria Investments LLC purchased a new stake in Iqvia in the fourth quarter worth $218,000. Finally, First Quadrant L P CA purchased a new stake in Iqvia in the fourth quarter worth $221,000. 95.79% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: “Analysts Anticipate Iqvia Holdings Inc (IQV) to Announce $1.34 EPS” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.com-unik.info/2018/02/08/analysts-anticipate-iqvia-holdings-inc-iqv-to-announce-1-34-eps.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.